Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera for Anemia in Pre-dialysis CKD
NCT00462384Phase 3Terminated
- Sponsor
- Roche
- Start
- Feb 2008
- Primary completion
- Apr 2011
- Modality
- Polymer-based Nanoparticles
- Countries
- 4
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started Feb 2008; status: terminated.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00462384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462384.